Arbutus Biopharma Stock Price

0.20 (6.71%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Arbutus Biopharma Corporation ABUS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.20 6.71% 3.18 19:49:54
Close Price Low Price High Price Open Price Previous Close
3.14 2.97 3.19 2.99 2.98
Bid Price Ask Price Spread News
3.14 3.17 0.03 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
10,508 3,747,460 $ 3.07 $ 11,496,239 3,774,516 0.81 - 9.00
Last Trade Time Type Quantity Stock Price Currency
19:44:55 5 $ 3.18 USD

Arbutus Biopharma Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 267.35M 84.07M 65.23M $ 6.01M $ - -2.89 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -20.00k 8.40%

more financials information »

Arbutus Biopharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ABUS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.423.38992.302.915,603,9120.7631.4%
1 Month3.333.442.302.873,023,081-0.15-4.5%
3 Months2.109.001.604.529,500,8531.0851.43%
6 Months1.269.000.884.154,859,1971.92152.38%
1 Year1.659.000.813.942,806,9351.5392.73%
3 Years5.0512.600.814.221,171,371-1.87-37.03%
5 Years7.5012.600.814.20789,074-4.32-57.6%

Arbutus Biopharma Description

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops and commercializes cure for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and also involved in licensing of Lipid nanoparticle technology.

Your Recent History
Arbutus Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.